NO774225L - PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES - Google Patents
PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUESInfo
- Publication number
- NO774225L NO774225L NO774225A NO774225A NO774225L NO 774225 L NO774225 L NO 774225L NO 774225 A NO774225 A NO 774225A NO 774225 A NO774225 A NO 774225A NO 774225 L NO774225 L NO 774225L
- Authority
- NO
- Norway
- Prior art keywords
- aziridine
- ester
- general formula
- carboxylic acid
- cyano
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 12
- RLZXKARDPOFVNB-UHFFFAOYSA-N aziridine-1-carboxylic acid Chemical group OC(=O)N1CC1 RLZXKARDPOFVNB-UHFFFAOYSA-N 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 37
- -1 amino, carbamoyloxy Chemical group 0.000 claims description 28
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
- 150000002367 halogens Chemical group 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- RMSRKYVNQYEPHO-UHFFFAOYSA-N 2-cyanoaziridine-1-carboxamide Chemical compound NC(=O)N1CC1C#N RMSRKYVNQYEPHO-UHFFFAOYSA-N 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000002560 nitrile group Chemical group 0.000 claims description 7
- 150000002825 nitriles Chemical group 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims description 5
- 125000005164 aryl thioalkyl group Chemical group 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 125000004001 thioalkyl group Chemical group 0.000 claims description 5
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000001541 aziridines Chemical class 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- BWFUMFVBFCNQIJ-UHFFFAOYSA-N 2-cyanoaziridine-1-carboxylic acid Chemical compound OC(=O)N1CC1C#N BWFUMFVBFCNQIJ-UHFFFAOYSA-N 0.000 description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- PGZUFTROELAOMP-UHFFFAOYSA-N aziridine-2-carbonitrile Chemical compound N#CC1CN1 PGZUFTROELAOMP-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- HIYGPZRASCFPMJ-UHFFFAOYSA-N ethyl 2-cyanoaziridine-1-carboxylate Chemical compound CCOC(=O)N1CC1C#N HIYGPZRASCFPMJ-UHFFFAOYSA-N 0.000 description 5
- 230000003308 immunostimulating effect Effects 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000007792 addition Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- KOUFWARDDJWPNI-UHFFFAOYSA-N ethyl 2-carbamoylaziridine-1-carboxylate Chemical compound CCOC(=O)N1CC1C(N)=O KOUFWARDDJWPNI-UHFFFAOYSA-N 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- SALMBGFIRZEDDJ-UHFFFAOYSA-N 2-carbamoylaziridine-1-carboxylic acid Chemical class NC(=O)C1CN1C(O)=O SALMBGFIRZEDDJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- LZRVAAYXGFWSDY-UHFFFAOYSA-N aziridine-2-carboxamide Chemical compound NC(=O)C1CN1 LZRVAAYXGFWSDY-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- DAHPCSIYQNSMET-UHFFFAOYSA-N methyl 2-carbamoylaziridine-1-carboxylate Chemical compound COC(=O)N1CC1C(N)=O DAHPCSIYQNSMET-UHFFFAOYSA-N 0.000 description 2
- CETKVTCUKOQKOP-UHFFFAOYSA-N phenyl 2-cyanoaziridine-1-carboxylate Chemical compound C1C(C#N)N1C(=O)OC1=CC=CC=C1 CETKVTCUKOQKOP-UHFFFAOYSA-N 0.000 description 2
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 2
- 239000010970 precious metal Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- SEMILPCRBUIZJO-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) carbonochloridate Chemical compound C1CC2(C)C(OC(Cl)=O)CC1C2(C)C SEMILPCRBUIZJO-UHFFFAOYSA-N 0.000 description 1
- XBTJZULRZQBGIT-UHFFFAOYSA-N (ethoxycarbonylamino) 4-nitrobenzenesulfonate Chemical class CCOC(=O)NOS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 XBTJZULRZQBGIT-UHFFFAOYSA-N 0.000 description 1
- AMOYMEBHYUTMKJ-UHFFFAOYSA-N 2-(2-phenylethoxy)ethylbenzene Chemical compound C=1C=CC=CC=1CCOCCC1=CC=CC=C1 AMOYMEBHYUTMKJ-UHFFFAOYSA-N 0.000 description 1
- HISPVKYXAHOFSZ-UHFFFAOYSA-N 2-amino-3-chloropropanenitrile;hydrochloride Chemical compound Cl.ClCC(N)C#N HISPVKYXAHOFSZ-UHFFFAOYSA-N 0.000 description 1
- MNQLVKDZYHGRNW-UHFFFAOYSA-N 2-diazoacetonitrile Chemical compound [N-]=[N+]=CC#N MNQLVKDZYHGRNW-UHFFFAOYSA-N 0.000 description 1
- ZFRQNZSPQOQABT-UHFFFAOYSA-N 2-ethoxycarbonylaziridine-1-carboxylic acid Chemical group CCOC(=O)C1CN1C(O)=O ZFRQNZSPQOQABT-UHFFFAOYSA-N 0.000 description 1
- GZMDPHINTMANCZ-UHFFFAOYSA-N 2-phenylethyl 2-cyanoaziridine-1-carboxylate Chemical compound C1C(C#N)N1C(=O)OCCC1=CC=CC=C1 GZMDPHINTMANCZ-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- QRONHXXURJUWNX-UHFFFAOYSA-N 2-propan-2-yloxycarbonylaziridine-1-carboxylic acid Chemical group C(C)(C)OC(=O)C1N(C1)C(=O)O QRONHXXURJUWNX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- BXEFQPCKQSTMKA-UHFFFAOYSA-N OC(=O)C=[N+]=[N-] Chemical class OC(=O)C=[N+]=[N-] BXEFQPCKQSTMKA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101150081514 Spef2 gene Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- AXNCITLGAIYHQM-UHFFFAOYSA-N aziridine-1,2-dicarboxylic acid Chemical compound OC(=O)C1CN1C(O)=O AXNCITLGAIYHQM-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- CWICICYLTKTMEM-UHFFFAOYSA-N benzyl 2-cyanoaziridine-1-carboxylate Chemical compound C1C(C#N)N1C(=O)OCC1=CC=CC=C1 CWICICYLTKTMEM-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 description 1
- IWVJLGPDBXCTDA-UHFFFAOYSA-N cyclohexyl carbonochloridate Chemical compound ClC(=O)OC1CCCCC1 IWVJLGPDBXCTDA-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- FRUZCHXSRCWUPH-UHFFFAOYSA-N cyclopentyl 2-cyanoaziridine-1-carboxylate Chemical compound C1C(C#N)N1C(=O)OC1CCCC1 FRUZCHXSRCWUPH-UHFFFAOYSA-N 0.000 description 1
- ZFQCRLNKHHXELH-UHFFFAOYSA-N cyclopentyl carbonochloridate Chemical compound ClC(=O)OC1CCCC1 ZFQCRLNKHHXELH-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- NTXPJWHBUBVAKX-UHFFFAOYSA-N cyclopropylmethyl 2-cyanoaziridine-1-carboxylate Chemical compound C1C(C#N)N1C(=O)OCC1CC1 NTXPJWHBUBVAKX-UHFFFAOYSA-N 0.000 description 1
- CUTUSCCYCWQYPQ-UHFFFAOYSA-N cyclopropylmethyl carbonochloridate Chemical compound ClC(=O)OCC1CC1 CUTUSCCYCWQYPQ-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- LQCNSMGLNLPUIE-UHFFFAOYSA-N ethyl aziridine-2-carboxylate Chemical compound CCOC(=O)C1CN1 LQCNSMGLNLPUIE-UHFFFAOYSA-N 0.000 description 1
- YVPJCJLMRRTDMQ-UHFFFAOYSA-N ethyl diazoacetate Chemical compound CCOC(=O)C=[N+]=[N-] YVPJCJLMRRTDMQ-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- MHNAGGWYMOVSIF-UHFFFAOYSA-N ethyl n-chloro-n-(2-chloro-1-cyanoethyl)carbamate Chemical compound CCOC(=O)N(Cl)C(CCl)C#N MHNAGGWYMOVSIF-UHFFFAOYSA-N 0.000 description 1
- MOGXYUCPGSDEAB-UHFFFAOYSA-N ethyl n-methylidenecarbamate Chemical class CCOC(=O)N=C MOGXYUCPGSDEAB-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- JUEYJVZDCUZWDX-UHFFFAOYSA-N oxolan-2-ylmethyl carbonochloridate Chemical compound ClC(=O)OCC1CCCO1 JUEYJVZDCUZWDX-UHFFFAOYSA-N 0.000 description 1
- RFTHAQFGKXKDCI-UHFFFAOYSA-N pentyl 2-cyanoaziridine-1-carboxylate Chemical compound CCCCCOC(=O)N1CC1C#N RFTHAQFGKXKDCI-UHFFFAOYSA-N 0.000 description 1
- XHRRYUDVWPPWIP-UHFFFAOYSA-N pentyl carbonochloridate Chemical compound CCCCCOC(Cl)=O XHRRYUDVWPPWIP-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FXIOCWHBOLDULW-UHFFFAOYSA-N phenyl 2-carbamoylaziridine-1-carboxylate Chemical compound NC(=O)C1CN1C(=O)OC1=CC=CC=C1 FXIOCWHBOLDULW-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- CAEWJEXPFKNBQL-UHFFFAOYSA-N prop-2-enyl carbonochloridate Chemical compound ClC(=O)OCC=C CAEWJEXPFKNBQL-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
- C07D203/20—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carbonic acid, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Fremgangsmåte ved fremstilling'av 1-aziridin-carboxylsyreester-derivater Process for the production of 1-aziridine carboxylic acid ester derivatives
Foreliggende oppfinnelse angår nye fremgangsmåter ved fremstilling av 1-aziridin-carboxylsyreester-derivater. The present invention relates to new methods for the production of 1-aziridine carboxylic acid ester derivatives.
I Tetrahedron Letters 1964, 2^97, beskriver W. Lwowski et al.. 2-cyan-l-aziridin-carboxylsyreethylesteren såvel som en fremgangsmåte for fremstilling av denne, men der gies ingen henvisning til en farmakologisk virkning. I rammen av arbeidene over 2-cyan-l-aziridin-carboxamid, et immunstimulerende terapeutikum ved bak-terie- og virus-infeksjoner (se tysk patent ansøkning P 25 28 460.0), har det nu vist seg at 2-cyan-1-aziridin-carboxylsyreethylest er er et egnet utgangsmateriale for fremstilling av dette terapeutikum. In Tetrahedron Letters 1964, 2^97, W. Lwowski et al. describe the 2-cyano-1-aziridine carboxylic acid ethyl ester as well as a method for its preparation, but no reference was made to a pharmacological effect. In the framework of the work on 2-cyan-l-aziridine-carboxamide, an immunostimulating therapeutic for bacterial and viral infections (see German patent application P 25 28 460.0), it has now been shown that 2-cyan-1- Aziridine carboxylic acid ethyl ester is a suitable starting material for the production of this therapeutic.
Det har overraskende vist seg at 2-cyan-1-aziridin-carboxylsyreethylesteren har en utpreget immunstimulerende virkning. Man står derfor overfor den oppgave å utvikle denne forbindelsestype videre, og å søke efter forbedrede fremgangsmåter for fremstilling av de kjente og nye forbindelser. It has surprisingly been shown that the 2-cyano-1-aziridine carboxylic acid ethyl ester has a distinct immunostimulating effect. One is therefore faced with the task of developing this type of compound further, and of searching for improved methods for the production of the known and new compounds.
Gjenstand for foreliggende oppfinnelse er nu nye fremgangsmåter ved fremstilling av forbindelsene med den generelle formel: The subject of the present invention is now new methods for the production of the compounds with the general formula:
hvor where
X er en nitril-, en carbamoyl- eller en alkoxycarbonylgruppe,X is a nitrile, a carbamoyl or an alkoxycarbonyl group,
R er en rettkjedet eller forgrenet, mettet eller umettet alkyl-gruppe, som eventuelt kan være substituert med halogen, alkoxy , amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R kan være cycloalkyl, aryl, aralkyl, aryloxyalkyl eller arylthioalkyl , idet arylgruppen eventuelt kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trif"luormethyl , R is a straight-chain or branched, saturated or unsaturated alkyl group, which may optionally be substituted with halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R may be cycloalkyl, aryl, aralkyl, aryloxyalkyl or arylthioalkyl, where the aryl group can optionally be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl,
såvel som anvendelsen av disse forbindelser ved fremstilling av legemidler med immunstimulerende virkning. as well as the use of these compounds in the preparation of pharmaceuticals with an immunostimulating effect.
Med alkyl menes i alle tilfelle en rettkjedet eller forgrenet kjede med 1-5 carbonatomer. Fortrinnsvis anvendes methyl-, ethyl-, isobutyl-, sek-butyl-, t-butyl- og n-pentylgruppen. Alkyl-kjedene kan eventuelt være substituert med halogen, som fluor, By alkyl is meant in all cases a straight-chain or branched chain with 1-5 carbon atoms. The methyl, ethyl, isobutyl, sec-butyl, t-butyl and n-pentyl groups are preferably used. The alkyl chains may optionally be substituted with halogen, such as fluorine,
klor og brom, eller en amino- eller hydroxygruppe. Som ytter-ligere substituenter finner carbamoyloxygruppen, fortrinnsvis 2-cyan-l-aziridin-carbonyloxygruppen, en imidogruppe, som f.eks. fthalimidogruppen, en heterocyclisk gruppe, særlig 2-tetrahydro-furyl- hhv. 2-tetrahydrothienylgruppen, alkoxy- eller cycloalkyl-gruppene anvendelse. Med alkoxy under substituentene X og R menes i alle tilfelle en gruppe med 1-5 carbonatomer, fortrinnsvis methoxy, ethoxy og isopropoxy. Med cycloalkyl forståes grupper med 3-10 carbonatomer, særlig cyclopropyl , cyclopentyl, cyclo-hexyl såvel som broinneholdende cycloalkylgrupper som f.eks. bor-nylgruppen. Som umettede alkylgrupper menes fremfor alt allyl- chlorine and bromine, or an amino or hydroxy group. As further substituents, the carbamoyloxy group, preferably the 2-cyan-1-aziridine carbonyloxy group, an imido group, such as e.g. the phthalimido group, a heterocyclic group, especially 2-tetrahydro-furyl or The 2-tetrahydrothienyl group, the alkoxy or cycloalkyl groups use. Alkoxy under the substituents X and R in all cases means a group with 1-5 carbon atoms, preferably methoxy, ethoxy and isopropoxy. Cycloalkyl means groups with 3-10 carbon atoms, especially cyclopropyl, cyclopentyl, cyclohexyl as well as bridge-containing cycloalkyl groups such as e.g. boron-nyl group. Unsaturated alkyl groups are above all allyl-
og crotylgruppen.and the crotyl group.
Som arylgruppe anvendes først og fremst aromater med 6 -As an aryl group, aromatics with 6 -
10 carbonatomer, som fenyl og nafthyl.10 carbon atoms, such as phenyl and naphthyl.
Aralkyl betegner fortrinnsvis benzyl og fenethyl, mens aryloxyalkyl betegner fortrinnsvis 2-fenoxyethy1, og arylthioalky1 betegner fortrinnsvis 2-f enylthioethyl . Aralkyl preferably denotes benzyl and phenethyl, while aryloxyalkyl preferably denotes 2-phenoxyethyl, and arylthioalkyl preferably denotes 2-phenylthioethyl.
Som thioalkyl anvendes først og fremst methylthio, og alkylsulfonyl er fortrinnsvis methylsulfonyl. Ved acylgruppen dreier det seg fortrinnsvis om formyl- og acetylgruppene. Med halogen menes fluor, klor og brom. Arylgruppen kan i alle tilfelle være substituert én eller flere ganger med de oppførte substituenter. As thioalkyl, methylthio is primarily used, and alkylsulfonyl is preferably methylsulfonyl. The acyl group is preferably the formyl and acetyl groups. Halogen means fluorine, chlorine and bromine. The aryl group can in all cases be substituted one or more times with the listed substituents.
Oppfinnelsens, gjenstand er dessuten samtlige st er eoisomere former av en forbindelse med den generelle formel I, som fåes på grunn av de asymmetriske carbonatomer. The object of the invention is also all isomeric forms of a compound of the general formula I, which are obtained due to the asymmetric carbon atoms.
Gjenstand for oppfinnelsen er videre de nye forbindelser med den generelle formel: The subject matter of the invention is further the new compounds with the general formula:
hvor where
X er en nit ril-, carbamoyl- eller alkoxycarbonylgruppe,X is a nitrile, carbamoyl or alkoxycarbonyl group,
R' er en rettkjedet eller forgrenet, mettet eller umettet alkyl-gruppe som eventuelt kan være substituert med halogen, alkoxy, R' is a straight-chain or branched, saturated or unsaturated alkyl group which may optionally be substituted with halogen, alkoxy,
amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R' kan være en cycloalkyl, aryl, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R' can be a cycloalkyl, aryl,
aralkyl, aryloxyalkyl eller arylthioalkyl, idet arylgruppen eventuelt kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trifluormethyl , aralkyl, aryloxyalkyl or arylthioalkyl, whereby the aryl group may optionally be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl,
idet når X er en nit rilgruppe, kan R<*>ikke være ethyl .in that when X is a nitrile group, R<*> cannot be ethyl .
Som allerede nevnt, har forbindelsene med den generelleAs already mentioned, the connections with the general have
formel I overraskende en utpreget immunstimulerende virkning. Dessuten er de, når X er en nitrilgruppe, verdifulle utgangsmaterialer for fremstilling av 2-cyan-l-aziridin-carboxamid. Til dette omsettes forbindelser med den generelle formel I hvor X er en nitrilgruppe, med ammoniakk under dannelse av 2-cyan-1-aziridin-carboxam id. formula I surprisingly has a distinct immunostimulating effect. Moreover, when X is a nitrile group, they are valuable starting materials for the preparation of 2-cyano-1-aziridine carboxamide. For this, compounds of the general formula I where X is a nitrile group are reacted with ammonia to form 2-cyan-1-aziridine-carboxamide.
Forbindelsene med den generelle formel I kan fremstilles vedThe compounds of the general formula I can be prepared by
i og for seg kjente fremgangsmåter, fortrinnsvis ved atmethods known in and of themselves, preferably in that
a) et aziridinderivat med den generelle formel:a) an aziridine derivative of the general formula:
hvor where
X er som ovenfor angitt, omsettes med en halogenmaursyreester med den generelle formel: X is, as stated above, reacted with a halogen formic acid ester of the general formula:
hvor R er som ovenfor angitt, og Hal er klor eller brom, eller b) en forbindelse med den generelle formel: where R is as indicated above, and Hal is chlorine or bromine, or b) a compound of the general formula:
hvor X, R og Hal er som ovenfor angitt, behandles med halogen-avspaltende reagenser, eller c) en forbindelse.med den generelle formel: where X, R and Hal are as indicated above, treated with halogen-releasing reagents, or c) a compound of the general formula:
hvor X og R er som ovenfor angitt, ved katalytisk eller fotokjemisk where X and R are as above, by catalytic or photochemical
nitrogénavspaltning overføres til en forbindelse med den generelle formel I, og at derpå eventuelt forbindelser med den generelle formel I overføres til andre forbindelser med den generelle nitrogen removal is transferred to a compound of the general formula I, and that subsequently compounds of the general formula I are subsequently transferred to other compounds of the general formula
formel I.formula I.
Den efterfølgende overføring av forbindelser med den generelle formel I til andre forbindelser med den generelle formel I kan eventuelt skje ved overføring av substituenten X. He.rved kan f.eks. forbindelser hvor X er alkoxycarbonyl, ved omsetning med ammoniakk overføres til forbindelser hvor X er carbamoyl, idet disse igjen med dehydratiseringsmidler kan overføres til forbindelser hvor X er nitril. The subsequent transfer of compounds with the general formula I to other compounds with the general formula I can optionally take place by transferring the substituent X. Here, e.g. compounds where X is alkoxycarbonyl, by reaction with ammonia are transferred to compounds where X is carbamoyl, as these can again be transferred with dehydrating agents to compounds where X is nitrile.
Forbindelser med den generelle formel I hvor X er alkoxycarbonyl og carbamoyl, kan derfor også anvendes som utgangsmaterialer ved fremstilling av forbindelsene med den generelle formel I hvor x er nitril, idet særlig 2-carbamoyl-1-aziridin-carboxylsyre-estere med den generelle formel i kommer i betraktning. Compounds of the general formula I where X is alkoxycarbonyl and carbamoyl can therefore also be used as starting materials in the preparation of the compounds of the general formula I where x is nitrile, particularly 2-carbamoyl-1-aziridine carboxylic acid esters of the general formula in comes into consideration.
Overføringen av ester-gruppen til amid-gruppen lar seg best utføre med gassformig ammoniakk i et organisk oppløsningsmiddel, fortrinnsvis .i methanol eller et ha noi.' Der anvendes fortrinnsvis ekvimolare mengder ammoniakk, og reaksjonen får forløpe ved fra 0°C til +5°C. Det ønskede amid isoleres fra reaksjonsblandingen'f.eks. ved søylekromatografi . The transfer of the ester group to the amide group can best be carried out with gaseous ammonia in an organic solvent, preferably in methanol or ethanol. Equimolar amounts of ammonia are preferably used, and the reaction is allowed to proceed at from 0°C to +5°C. The desired amide is isolated from the reaction mixture, e.g. by column chromatography.
Ved overføringen av carbamoylgruppen til nit rilgruppen anvendes kjente dehydratiseringsmidler, idet der fremfor alt anvendes blandingen av trifenylfosfin, carbontetraklorid og triethylamin. Som oppløsningsmiddel anvendes vanligvis halogenerte hydrocarboner, f.eks. methylenklorid eller kloroform. Det ønskede nitril isoleres som regel fra reaksjonsblandingen ved destillasjon. In the transfer of the carbamoyl group to the nitrile group, known dehydrating agents are used, in which above all the mixture of triphenylphosphine, carbon tetrachloride and triethylamine is used. Halogenated hydrocarbons are usually used as solvents, e.g. methylene chloride or chloroform. The desired nitrile is usually isolated from the reaction mixture by distillation.
På den annen side kan f.eks. også substituentene R og R'. overføres til hverandre ved generelle fremgangsmåter for omestring, idet i alminnelighet en liten tilsetning av en basisk forbindelse f.eks. et alkali- eller jordalkalimetallhydroxyd eller et alkali-alkoholat er nødvendig. On the other hand, e.g. also the substituents R and R'. are transferred to each other by general methods for transesterification, as generally a small addition of a basic compound, e.g. an alkali or alkaline earth metal hydroxide or an alkali alcoholate is required.
Dessuten kan de nye forbindelser med den generelle formel I' fremstilles ved omsetning av nitrener med den generelle formel: hvor R' er som ovenfor angitt, med forbindelser.med den generelle formel: Moreover, the new compounds of the general formula I' can be prepared by reacting nitrenes of the general formula: where R' is as indicated above, with compounds of the general formula:
hvor X er som ovenfor angitt. where X is as indicated above.
Nitrener med den generelle formel VI, som kan fremstilles intermediært ved fotolyse av azidomaursyreestere eller ved u-eliminering ved hjelp av baser som triethylamin fra N-p-nitro-benzensulfonyloxyurethaner, reagerer uten videre med de anvendte acrylsyrederivater til de ønskede aziridiner med den generelle formel i<>>(f.eks. Tetrahedron Letters, 1964, 2497; J. Am. chem. soc. 87, 3630 [1965]) . Nitrenes of the general formula VI, which can be prepared intermediately by photolysis of azidomauric acid esters or by u-elimination with the aid of bases such as triethylamine from N-p-nitro-benzenesulfonyloxyurethanes, react readily with the acrylic acid derivatives used to the desired aziridines of the general formula i< >>(eg Tetrahedron Letters, 1964, 2497; J. Am. chem. soc. 87, 3630 [1965]) .
Ved fremgangsmåte a) kan reaksjonspartnerne omsettes i inerte oppløsningsmidler som f.eks. diethylether, methylenklorid, benzen eller toluen i nærvær av en base. Som baser anvendes fortrinnsvis tertiære aminer som f.eks. triethylamin eller triethanolamin. Like så godt kan man imidlertid arbeide i et tofasesystem som vann/diet hylet her, idet der da fortrinnsvis anvendes uorganiske baser, særlig natriumcarbonat. Som halogenmaursyreestere anvendes som regel klormaursyreesterne. Disse er til dels beskrevet i litteraturen, men ellers kan de.fremstilles ved i og for seg kjente metoder ved omsetning av den tilsvarende alkohol, hhv. fenol, med fosgen i nærvær av en base som pyridin eller N,N-dimethyla nilin. Klormaursyreesterne renses som regel ved destillasjon, men om- In method a), the reaction partners can be reacted in inert solvents such as e.g. diethyl ether, methylene chloride, benzene or toluene in the presence of a base. Tertiary amines are preferably used as bases, such as e.g. triethylamine or triethanolamine. However, it is equally possible to work in a two-phase system such as water/diet here, as inorganic bases are then preferably used, especially sodium carbonate. Chloroformic acid esters are usually used as haloformic acid esters. These are partly described in the literature, but otherwise they can be produced by methods known per se by reacting the corresponding alcohol, or phenol, with phosgene in the presence of a base such as pyridine or N,N-dimethyla niline. The chloroformate esters are usually purified by distillation, but if
settes eventuelt videre også som råprodukt.possibly also passed on as a raw product.
De ved fremgangsmåte b) anvendte dihaldgenforbindelser erThe dihaldene compounds used in method b) are
nye og kan fremstilles ved omsetning av de tilsvarende forbindelser som ikke er halogenert ved .nitrogenatomet, med halogenerings-midler, som f.eks. natriumhypohalogenit eller t-butylhypoklorit. For avspaltning av de to halogenatomer til aziridinderivatet med new and can be produced by reacting the corresponding compounds which are not halogenated at the nitrogen atom with halogenating agents, such as e.g. sodium hypohalite or t-butyl hypochlorite. For splitting off the two halogen atoms of the aziridine derivative with
den generelle formel I kan man anvende vanlige dehalogenerings-midler, fortrinnsvis zink eller natrium. in the general formula I, common dehalogenating agents can be used, preferably zinc or sodium.
De ved fremgangsmåte c) anvendte triazolinderivater er nyeThe triazoline derivatives used in method c) are new
og kan fremstilles ved omsetning av diazoeddiksyrederivater som f.eks. diazoeddiksyreethylester eller diazoacetonitril med methylenurethaner. Nitrogenavspaltningen skjer enten ved belysning i et oppløsningsmiddel som f.eks. diethylether eller aceton, eller katalytisk. Som katalysatorer anvendes edelmetaller eller halv-edelmetaller, fortrinnsvis kobberpulver. and can be produced by reacting diazoacetic acid derivatives such as e.g. diazoacetic acid ethyl ester or diazoacetonitrile with methylene urethanes. The nitrogen removal takes place either by illumination in a solvent such as e.g. diethyl ether or acetone, or catalytic. Precious metals or semi-precious metals, preferably copper powder, are used as catalysts.
For fremstilling av farmasøytiske midler med immunstimulerende virkning blandes forbindelsene med den generelle formel I på i og for seg kjent vis med egnede farmasøytiske bærere, og opparbeides eksempelvis som tabletter eller dragéer, eller suspenderes eller oppløses under tilsetning av tilsvarende hjelpestoffer i vann eller olje, f.eks. olivenolje, og fylles i stikk-kapsler. Da virkestoffet er syrelabilt, forsynes preparatet med et overtrekk som først er oppløselig i det alkaliske tynntarmsmiljø eller blandes med et tilsvarende bærestoff, som f.eks. en høyere fettsyre eller carboxy-methylcellulose. Faste bærestoffer er f.eks. stivelse, lactose, mannit, methylcellulose, talkum, høydisperse kiselsyrer, høyere-molekylære fettsyrer (som stearinsyre), gelatin, agar-agar, calcium-fosfat, magnesiumstearat, animalske og vegetabilske fett og faste høymolekylære polymerer (som polyethylenglycoler), for oral admini-strasjon egnede preparater kan eventuelt smaks- og søtstoffer tilsettes. For the production of pharmaceutical agents with an immunostimulating effect, the compounds of the general formula I are mixed in a manner known per se with suitable pharmaceutical carriers, and processed for example as tablets or dragees, or suspended or dissolved with the addition of corresponding excipients in water or oil, f .ex. olive oil, and filled in pop-up capsules. As the active substance is acid-labile, the preparation is supplied with a coating that is first soluble in the alkaline small intestinal environment or mixed with a corresponding carrier, such as e.g. a higher fatty acid or carboxy-methylcellulose. Solid carriers are e.g. starch, lactose, mannitol, methylcellulose, talc, highly dispersed silicic acids, higher-molecular fatty acids (such as stearic acid), gelatin, agar-agar, calcium phosphate, magnesium stearate, animal and vegetable fats and solid high-molecular polymers (such as polyethylene glycols), for oral administration -stration suitable preparations can optionally have flavorings and sweeteners added.
Som injeksjonsmedium kommer fortrinnsvis vann til anvendelse, som inneholder de for injeksjonsoppløsninger. vanlige tilsetninger som stabiliseringsmidler, oppløsningsformidlere eller svakt As an injection medium, water is preferably used, which contains those for injection solutions. common additives such as stabilizers, solubilizers or weakly
alkaliske puffere. Slike tilsetninger er f.eks. fosfat- eller carbonatpuffere, ethanol, kompleksdannere (som ethylendiamintet ra - eddiksyre og dens ikke-giftige salter), høymolekylære polymerer (som flytende polyethylenoxyd) for viskositetsregulering. alkaline buffers. Such additions are e.g. phosphate or carbonate buffers, ethanol, complexing agents (such as ethylenediaminetetraacetic acid and its non-toxic salts), high molecular weight polymers (such as liquid polyethylene oxide) for viscosity control.
Foretrukket ved foreliggende oppfinnelse er foruten de i de følgende eksempler nevnte forbindelser, også de følgende: 2-cyan-1-aziridin-carboxylsyre-(1-klorethylester) 2-cyan-l-aziridin-carboxylsyre-(1,2-diklorethylester) 2-cyan-l-aziridin-carboxylsyre-(1,2,2,2-tetraklorethylester) 2-cyan-1-aziridin-carboxylsyre-(2-methylfenylester) 2-cyan-1-aziridin-carboxylsyre -(2-methoxyfenylester) 2-cyan-l-aziridin-carboxylsyre-(2-klorf enylest er) 2-cyan-l-aziridin-carboxylsyre-(3-klorfenylester) 2-cyan-l-aziridin-carboxylsyre-(2,4 > 6-tribromfenylester) 2-cyan-l-aziridin-carboxylsyre-(2-nit rof enylester) 2-cyan-l-aziridin-carboxylsyre-(2-aminof enylester) 2-cyan-l-aziridin-carboxylsyre-(3-aminofenylester) 2-cyan-1-aziridin-carboxylsyre-(4-aminof enylest er) 2-cyan-l-aziridin-ca rboxylsyre-(2-hydroxyf enylest er) 2-cyan-l-aziridin-carboxylsyre-(4-hydroxyfenylester) 2-cyan-1-a ziridin-carboxylsyre-(2-t rifluormethylfenylest er) 2-cyan-l-aziridin-ca rboxylsyre-(3-t rifluormethylfenylest er) 2-cyan-l-aziridin-ca rboxylsyre-(4-nitrobenzylest er) 2-cyan-l-aziridin-carboxylsyre-(2-hydroxyet hylest er) 2-cy.an-1-a zir idin-ca rboxylsyre-cyclopropy lest er 2-cyan-1-aziridin-carboxylsyre-(2,2,2-t rifluoret hylest er) 2-cyan-1-aziridin-carboxylsyre-(2-propoxyet hylester) 2-carbamoyl-1-aziridin-carboxylsyré-benzylest er 2-carbamoyl-1-aziridin-carboxylsyre-cyclohexylest er 2-carbamoyl-1-aziridin-carboxylsyre-(4-klorf enylester) 1- ethoxycarbony1-2-aziridin-ca rboxylsyre-isopropylest er 2- ethoxycarbonyl-1-aziridin-carboxylsy re-f enylest er 2-isopropoxycarbonyl-1-aziridin-carboxylsyre-(2,2,2-t riklorethyl- ester) 2-ethoxycarbonyl-1-aziridin-carboxylsyre-allylest ér Preferred in the present invention are, in addition to the compounds mentioned in the following examples, also the following: 2-cyano-1-aziridine-carboxylic acid-(1-chloroethyl ester) 2-cyano-1-aziridine-carboxylic acid-(1,2-dichloroethyl ester) 2-cyano-l-aziridine carboxylic acid-(1,2,2,2-tetrachloroethyl ester) 2-cyano-1-aziridine carboxylic acid-(2-methylphenyl ester) 2-cyano-1-aziridine carboxylic acid -(2-methoxyphenyl ester ) 2-cyano-l-aziridine carboxylic acid-(2-chlorophenyl ester) 2-cyano-l-aziridine carboxylic acid-(3-chlorophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2,4 > 6- tribromophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-nitrophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-aminophenyl ester) 2-cyano-l-aziridine carboxylic acid-(3-aminophenyl ester) 2-cyano-1-aziridine carboxylic acid-(4-aminophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-hydroxyphenyl ester) 2-cyano-l-aziridine carboxylic acid-(4-hydroxyphenyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-trifluoromethylphenyl ester) 2-cyano-1-aziridine-carboxylic acid-(3-trifluoromethylphenyl ester) 2-cyan -1-aziridine-ca rcarboxylic acid-(4-nitrobenzyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-hydroxy ester) 2-cyano-1-a ziridine-ca rcarboxylic acid-cyclopropyl ester 2 -Cyano-1-aziridine-carboxylic acid-(2,2,2-trifluorinated ester) 2-Cyano-1-aziridine-carboxylic acid-(2-propoxyethyl ester) 2-Carbamoyl-1-aziridine-carboxylic acid-benzyl ester 2 -carbamoyl-1-aziridine-carboxylic acid-cyclohexyl ester is 2-carbamoyl-1-aziridine-carboxylic acid-(4-chlorophenyl ester) 1- ethoxycarbonyl-1-2-aziridine-carboxylic acid-isopropyl ester is 2- ethoxycarbonyl-1-aziridine-carboxylic acid -phenylest is 2-isopropoxycarbonyl-1-aziridine-carboxylic acid-(2,2,2-trichloroethyl- ester) 2-ethoxycarbonyl-1-aziridine carboxylic acid allyl ester
De følgende eksempler viser noen av de tallrike fremgangs-måtevarianter som kan anvendes til syntesen av f remga ngsmåt ef or - bindelsene. The following examples show some of the numerous process variants that can be used for the synthesis of process ef or - compounds.
Eksempel 1Example 1
2- cyan-l-a ziridin- carboxylsyre- fenylester2- cyano-l-a ziridine- carboxylic acid- phenyl ester
Til 6,8 g 2-cyanaziridin i 70 ml vann tilsettes ved værelsetemperatur samtidig en oppløsning av 12,6 g klormaursyre-fenylester i 40 ml diethylether og 40 ml 2 N sodaoppløsning. Der omrøres i videre i 2 timer ved værelsetemperatur, fasene skilles, ether-skiktet ekstraheres to ganger med vann, tørres, og den organiske fase inndampes. Residuet omkrystalliseres fra diisopropylether. Utbytte: 10,39(67%). Smp. 60-62°C. To 6.8 g of 2-cyanaziridine in 70 ml of water, a solution of 12.6 g of chloroformic acid phenyl ester in 40 ml of diethyl ether and 40 ml of 2 N soda solution is simultaneously added at room temperature. The mixture is stirred for a further 2 hours at room temperature, the phases are separated, the ether layer is extracted twice with water, dried, and the organic phase is evaporated. The residue is recrystallized from diisopropyl ether. Yield: 10.39(67%). Temp. 60-62°C.
På analogt vis får man ved omsetning av 2-cyanaziridin medAnalogously, one obtains by reacting 2-cyanaziridine with
1. Klormaursyremethylester 2-cyan-1-aziridin-carboxylsyre-methylester 1. Chloroformate methyl ester 2-cyano-1-aziridine carboxylic acid methyl ester
KP0,02: 70 - 72°C KP0.02: 70 - 72°C
2. Klormaursyre-(2,2,2-triklorethylester) 2- cyan- l- aziridin- carboxylsyre-( 2, 2, 2- t riklorethylest er) 2. Chloroformic acid-(2,2,2-trichloroethyl ester) 2-cyano-l-aziridine-carboxylic acid-(2,2,2-trichloroethyl ester)
KpQ 1 : 138 - 139°C Smp.: 86 - 88°C (diisopropylether) KpQ 1 : 138 - 139°C Mp.: 86 - 88°C (diisopropyl ether)
3- Klormaursyre-allylester 3- Chloroformic acid allyl ester
2- cyan- l - a zi r id in- ca rboxy 1 syre- a Hylest er2- cyan- l - azi r id in- ca rboxy 1 acid- a Hylest is
KpQ 2 : 102 - 105°C KpQ 2 : 102 - 105°C
4> Klormaursy re-t -butylester (anvendt som etherisk oppløsning) 4> Chlormaursy re-t-butyl ester (used as ethereal solution)
2- cya n- 1- a ziridin- ca rboxylsyre-t-butylest er2- cyano- 1-a ziridine-ca rboxylic acid-t-butyl ester is
k<p>0,oi: 57 * 59°ck<p>0.oi: 57 * 59°c
5. Klormaursyre-n-pentyleste<r>(Kp100 : 98 - 100°C) 2- cyan- l- aziridin- carboxylsyre-n-pentylest er 5. Chloroformate-n-pentyl ester<r>(Kp100 : 98 - 100°C) 2-cyano-l-aziridine-carboxylic acid-n-pentyl ester is
k<p>0,oi: 93°ck<p>0.0i: 93°c
6.Klormaursyre-cyclohexylester (Kp^: 47°C) 2- cyan- l- azirid in-ca rboxylsyre-cyclohexylest er 6. Chloroformic acid cyclohexyl ester (Kp^: 47°C) 2-cyano-l-aziride in-ca rboxylic acid cyclohexyl ester is
k<p>0,oi: 97°ck<p>0.0i: 97°c
7« Klormaursyre-benzylester 7« Chloroformic acid benzyl ester
2- cyan- 1- aziridin- carboxylsyre-benzylest er2- cyano- 1- aziridine- carboxylic acid benzyl ester
kp0,oi : 145"150°c bp0,oi : 145"150°c
8. Klormaursyre-fenethylester (KP]_g : 120°C) 2- cyan- l- aziridin- carboxylsyre- fenethylest er 8. Chloroformic acid phenethyl ester (KP]_g : 120°C) 2-cyano-l-aziridine-carboxylic acid phenethyl ester is
KP0,oi: 130°c KP0,oi: 130°c
Eksempel 2Example 2
1,2-aziridin-dic arboxylsyre- diethylest er1,2-aziridine-dic carboxylic acid diethyl ester is
Til 2 g 2-aziridin-carboxylsyre-ethylester og 1,79triethylamin 1 20 ml benzen tildryppes ved 0°C en oppløsning av 1,9 g klormaursyre-ethylester i 10 ml benzen, der omrøres så i 2 timer ved værelsetemperatur, ekstraheres tre ganger med vann, benzenfasen tørres i og inndampes. Residuet blir så destillert. To 2 g of 2-aziridine carboxylic acid ethyl ester and 1,79 triethylamine 1 20 ml of benzene is added dropwise at 0°C a solution of 1.9 g of chloroformic acid ethyl ester in 10 ml of benzene, which is then stirred for 2 hours at room temperature, extracted three times with water, the benzene phase is dried and evaporated. The residue is then distilled.
•*Utbytte: 2,0 g (62%). KpQ 2 : 94° C•*Yield: 2.0 g (62%). KpQ 2 : 94°C
Eksempel 3Example 3
2-carbamoyl-1-aziridin- carboxylsyre- feny lester2-carbamoyl-1-aziridine carboxylic acid phenyl ester
Til 2,6 g 2-aziridin-carboxamid i 20 ml vann tildryppes ved 0°C samtidig en oppløsning av 4,79klormaursyre-fenylester i 20 ml diethylether og 30 ml 2 N sodaoppløsning. Omrøringen fortsettes i 10 minutter under isavkjøling, bunnfallet frasuges og vaskes godt med ether. To 2.6 g of 2-aziridine carboxamide in 20 ml of water is simultaneously added dropwise at 0°C a solution of 4.79 chloroformic acid phenyl ester in 20 ml of diethyl ether and 30 ml of 2 N soda solution. Stirring is continued for 10 minutes under ice cooling, the precipitate is suctioned off and washed well with ether.
Utbytte: 4,4 g (71%). Smp.: 140 - l42°C fra toluen.Yield: 4.4 g (71%). M.p.: 140 - 142°C from toluene.
Eksempel 4Example 4
2 - cya n- 1 - a zi r idin- carboxylsy r e- a Hy les ter2 - cyan- 1 - azi ridine- carboxylsy r e- a Hy les ter
Til 2 g 2-cyanaziridin i 20 ml benzen og 39triethylamin tilsettes ved 0°C 3,2 g klormaursyre-allylester i 20 ml benzen. Omrøringen fortsettes i 2 timer ved værelsetemperatur, benzenopp-løsningen ekstraheres to ganger med vann, tørres, og den organiske fase inndampes. Residuet destilleres så. To 2 g of 2-cyanaziridine in 20 ml of benzene and 39triethylamine, 3.2 g of chloroformic acid allyl ester in 20 ml of benzene are added at 0°C. Stirring is continued for 2 hours at room temperature, the benzene solution is extracted twice with water, dried, and the organic phase is evaporated. The residue is then distilled.
Utbytte: 2,9 g (64,5%). KpQ 2 : 102 - 105°CYield: 2.9 g (64.5%). KpQ 2 : 102 - 105°C
På analogt vist får man ved omsetning av 2-cyanaziridin med klormaursyre-ethylest er Analogously, one obtains by reacting 2-cyanaziridine with chloroformic acid ethyl ester
2- cyan- l-azi ridin-ca rboxylsyre-ethylest er2- cyano-l-aziridin-ca rboxylic acid-ethyl ester
Kpo'^o7T~o -75°cKpo'^o7T~o -75°c
Eksempel 5Example 5
2- carbamoyl-1-aziridin-carboxylsyre-ethylest er2- carbamoyl-1-aziridine-carboxylic acid ethyl ester is
Til 2,6 g 2-aziridin-carboxamid i 20 ml vann tildryppes2.6 g of 2-aziridine carboxamide in 20 ml of water is added drop by drop
under isavkjøling samtidig en oppløsning, av 3,25 g klormaursyre- under ice-cooling at the same time a solution of 3.25 g of chloroformate
ethylester i 20 ml diethylether og 15 ml 2 N sodaoppløsning. Reaksjonsblandingen omrøres videre i 1 time under avkjøling, ethyl ester in 20 ml of diethyl ether and 15 ml of 2 N soda solution. The reaction mixture is further stirred for 1 hour while cooling,
skiktene skilles, den vandige fase inndampes, og residuet utkokes med ethanol. Ethanoloppløsningen filtreres, inndampes, og resi- the layers are separated, the aqueous phase is evaporated, and the residue is boiled off with ethanol. The ethanol solution is filtered, evaporated, and resi-
duet omkryst alliseres fra toluen.duet omcross is allized from toluene.
Utbytte: 2,6 g (56%). Smp.: 125 - 128°C.Yield: 2.6 g (56%). Melting point: 125 - 128°C.
På analogt vis får man ved omsetning av 2-aziridin-Analogously, by reacting 2-aziridine-
carboxamid med klormaursyre-methylester carboxamide with chloroformic acid methyl ester
2- carbamoyl- 1- aziridin- carboxylsyre- methylest er2- carbamoyl- 1- aziridine- carboxylic acid- methyl ester
Smp.: 117 - 120°C (fra toluen). 1 Mp.: 117 - 120°C (from toluene). 1
Eksempel 6Example 6
Fremstilling av .2-cyan-1-aziridin-carboxamid fra 2- cyan- 1- aziridin-carboxylsyre-fenylest er Preparation of .2-cyano-1-aziridine-carboxamide from 2-cyano-1-aziridine-carboxylic acid phenyl ester is
1,9 g 2-cyan-1-aziridin-carboxylsyre-fenylester oppløses i1.9 g of 2-cyano-1-aziridine carboxylic acid phenyl ester is dissolved in
30 ml diethylether og tildryppes 20 ml flytende ammoniakk. Der omrøres i 2 timer ved temperaturen for den kokende ammoniakk, opp-løsningen får lov til å anta værelsetemperatur over natten, og det'utfelte 2-cyan-1-aziridin-carboxamid avsuges. 30 ml of diethyl ether and add 20 ml of liquid ammonia drop by drop. The mixture is stirred for 2 hours at the temperature of boiling ammonia, the solution is allowed to reach room temperature overnight, and the precipitated 2-cyano-1-aziridine carboxamide is filtered off with suction.
Utbytte: 0,85 g (77%). Smp.: 74 - 76°C.Yield: 0.85 g (77%). Melting point: 74 - 76°C.
Eksempel 7Example 7
2 - cya n- 1 - a zi r idin- carboxy lsyre- met.hy lest er2 - cyan- 1 - azi ridine- carboxy lsyre- met.hy lest er
Til en oppløsning av 27,5 Q trifenylfosfin, 10,1 g triethylamin og 15,4 g carbontetraklorid i 300 ml methylenklorid tilsettes 14,4 g 2-carbamoyl-1-aziridin-carboxylsyre-methylester, og blandingen kokes under tilbakeløp i 4 timer. Reaksjonsblandingen filtreres, oppløsningen ekstraheres to ganger med vann, den organiske fase tørres og inndampes. Residuet destilleres. To a solution of 27.5 Q of triphenylphosphine, 10.1 g of triethylamine and 15.4 g of carbon tetrachloride in 300 ml of methylene chloride, 14.4 g of 2-carbamoyl-1-aziridine carboxylic acid methyl ester is added, and the mixture is refluxed for 4 hours . The reaction mixture is filtered, the solution is extracted twice with water, the organic phase is dried and evaporated. The residue is distilled.
Utbytte: 3,4 g (27%). KpQ Q2 : 70 - 72°C.Yield: 3.4 g (27%). KpQ Q2 : 70 - 72°C.
Eksempel 8Example 8
2- carbamoyl- l- aziridin- carboxylsyre-ethylest er2- carbamoyl-l-aziridine-carboxylic acid ethyl ester
Til 4,67 g (0,025 mol) 1,2-aziridin-dicarboxylsyre-diethy1-ester i 30 ml ethanol tilsettes den ekvimolare mengde gassformig ammoniakk oppløst i ethanol, og oppløsningen hensettes over natten i kjøleskap. Der inndampes, og den.ønskede 2-carbamoyl-1-aziridin-carboxylsyre-ethylester isoleres ved søylekromatografi (200 g sili-cagel, elueringsmiddel aceton/toluen vplumforhold 1:1). To 4.67 g (0.025 mol) of 1,2-aziridine dicarboxylic acid diethy ester in 30 ml of ethanol is added the equimolar amount of gaseous ammonia dissolved in ethanol, and the solution is left overnight in a refrigerator. It is evaporated, and the desired 2-carbamoyl-1-aziridine-carboxylic acid ethyl ester is isolated by column chromatography (200 g silica gel, eluent acetone/toluene volume ratio 1:1).
Utbytte: 1,4 g (32%). Smp.: 125 - 128°C.Yield: 1.4 g (32%). Melting point: 125 - 128°C.
Eksempel 9Example 9
Fremstilling av 2-cyan-l-aziridin-carboxamid fra 2-cyan-l-azir idin- ca rboxy lsyre- et hy le st er Preparation of 2-cyan-l-aziridine-carboxamide from 2-cyan-l-aziridine-ca rboxylic acid- et hy le st er
4 g 2-cyan-l-aziridin-carboxylsyre-ethylester tilsettes til4 g of 2-cyano-1-aziridine carboxylic acid ethyl ester are added
en oppløsning av 0,79ammoniakkgass i 80 ml vann. Blandingen omrøres ved værelsetemperatur i 4 timer, ekstraheres tre ganger med ethylether, og vannfasen frysetørres så.. Residuet omkrystalliseres fra ethanol under tilsetning av diethylether. a solution of 0.79 ammonia gas in 80 ml of water. The mixture is stirred at room temperature for 4 hours, extracted three times with ethyl ether, and the aqueous phase is then freeze-dried. The residue is recrystallized from ethanol with the addition of diethyl ether.
Utbytte: 1,059(29%). Smp.: 74 - 76°C.Yield: 1.059(29%). Melting point: 74 - 76°C.
Eksempel 10 Example 10
2-cyan-1-a ziri din- carboxylsyre- ethylester2-Cyano-1-aziridin- carboxylic acid ethyl ester
Til 2,11 g 2-(N-carbethoxy-N-klor-amino)-3-klorpropionitril (oljeaktig forbindelse, fremstilt ved omsetning av 2-amino-3~klorpropionitril-hydroklorid (smp. 153 _ 155°C) med klormaursyre-ethylester i nærvær av natriumcarbonat med påfølgende omsetning med t-butylhypoklorit) i 25 ml tethanol tilsettes 0,339aktivert zinkstøv og noe zinkklorid, blandingen omrøres i 12 timer ved værelsetemperatur., avsuges , filtratet inndampes, og residuet destilleres. To 2.11 g of 2-(N-carbethoxy-N-chloro-amino)-3-chloropropionitrile (oily compound, prepared by reacting 2-amino-3-chloropropionitrile hydrochloride (m.p. 153 - 155°C) with chloroformic acid -ethyl ester in the presence of sodium carbonate with subsequent reaction with t-butyl hypochlorite) in 25 ml of ethanol, 0.339 activated zinc dust and some zinc chloride are added, the mixture is stirred for 12 hours at room temperature, filtered off, the filtrate is evaporated, and the residue is distilled.
Utbytte:0,11g (8%). KpQ 01 : 78 - 80°C.Yield: 0.11g (8%). KpQ 01 : 78 - 80°C.
Eksempel 11Example 11
Som beskrevet i eksempel 1, får man ved omsetning av 2-cyan-aziridin med: 1. Klormaursyre-isobutylester 2- cyan- l- aziridin-carboxylsyre-isobut ylest er KpQ 1 : 108 - 110°C 2.Klormaursyre-cyclopropyl-methylester (Kp12: 45 - 46°C) 2- cyan- l- aziridin- carboxylsyre- cyclopropyl- methylest er KpQ)1: 107 - 109°C 3. Klormaursyre-(but-2-enylester) (Kp O , J- 25 - 28°C) 2- cyan- 1- aziridin- carboxylsyre-( but-2-enyl est er) As described in example 1, one obtains by reacting 2-cyano-aziridine with: 1. Chloroformic acid isobutyl ester 2-cyano-l-aziridine carboxylic acid isobutyl ester is KpQ 1 : 108 - 110°C 2. Chloroformic acid cyclopropyl- methyl ester (Kp12: 45 - 46°C) 2- cyano-l-aziridine-carboxylic acid- cyclopropyl- methyl ester is KpQ)1: 107 - 109°C 3. Chloroformate-(but-2-enyl ester) (Kp O , J- 25 - 28°C) 2-cyano-1-aziridine-carboxylic acid-(but-2-enyl ester)
oljeaktig produktoily product
4. Klormaursyre-cyclopentylester (Kp^: 6o -,6l°C) 2- cyan- l- aziridin- carboxylsyre-cyclopentylest er 4. Chloroformic acid cyclopentyl ester (Kp^: 60 -.61°C) 2-cyano-l-aziridine-carboxylic acid cyclopentyl ester is
oljeaktig produktoily product
5. Klormaursyre-bornylester (Kp2: 108 - H0°C) 2- cyan- l- aziridin- carboxylsyre- bornylester 5. Chloroformic acid-bornyl ester (Kp2: 108 - H0°C) 2-cyano-l-aziridine-carboxylic acid-bornyl ester
Kp0)1: 153°C Kp0)1: 153°C
6. Klormaursyre-(2-fluorethylester) (Kp : 110 - 113°C) 2- cyan- l- aziridin- carboxylsyre-( 2- fluorethylester) Kp0)1: 120°C 7. Klormaursyre-(2-klorethylester) (Kp^Q: 83 - 86°C) 2- cyan- 1- aziridin- carboxylsyre-( 2- klorethylest er) oljeaktig produkt 8. Klormaursyre-(2-brometh<y>lest er) 2- cyan- 1- a ziridin- carboxylsyre-( 2- bromethylester) oljeaktig produkt 9 . Klormaursyre-(2-methoxyethylester) 2- cyan- l- aziridin- carboxylsyre-( 2- methoxyethylester) KpQ x : 119-120°C 10. Klormaursyre-tetrahydrofurfurylester (KpQ 2 : 68°C) 2- cyan- 1- aziridin- carboxylsyre- tet rahydrofurf urylester oljeaktig produkt 11. Et hylenglycol-1,2-bis-klormaursyreester (KPg^: H0°C) 1, 2-[ bis-( 2- cyanaziridin- l- ca rbonyloxy)]-etha n oljeaktig produkt 12. Klormaursyre-(2-fenoxyethylester) (KpQ1: 97 - 99°C) 2- cyan- l- a ziridin- carboxylsyre-( 2- f enoxyethylest er) oljeaktig produkt 13. Klormaursyre-(2-fenyl-thioethylester) 2- cyan- 1- aziridin- carboxylsyre-( 2- feny1- thioethylester) oljeaktig produkt 6. Chloroformic acid-(2-fluoroethyl ester) (Kp : 110 - 113°C) 2-cyano-l-aziridine-carboxylic acid-(2-fluoroethyl ester) Kp0)1: 120°C 7. Chloroformic acid-(2-chloroethyl ester) ( Kp^Q: 83 - 86°C) 2-cyano-1-aziridine-carboxylic acid-(2-chloroethyl ester) oily product 8. Chloroformic acid-(2-bromometh<y>lester) 2-cyano-1-a ziridine - carboxylic acid-(2-bromomethyl ester) oily product 9 . Chloroformic acid-(2-methoxyethyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-methoxyethyl ester) KpQ x : 119-120°C 10. Chloroformic acid-tetrahydrofurfuryl ester (KpQ 2 : 68°C) 2-cyano-1-aziridine - carboxylic acid tetrahydrofurfur uryl ester oily product 11. A hylene glycol-1,2-bis-chloroformic acid ester (KPg^: H0°C) 1, 2-[ bis-(2- cyanaziridin-1-ca rbonyloxy)]-etha n oily product 12. Chloroformic acid-(2-phenoxyethyl ester) (KpQ1: 97 - 99°C) 2-cyano-l-aziridine-carboxylic acid-(2-phenoxyethyl ester) oily product 13. Chloroformic acid-(2-phenyl-thioethyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-phenyl-1-thioethyl ester) oily product
14- Klormaursyre-(l-nafthylester) (KpQ ^ : 86 - 90°C) 14- Chloroformate-(l-naphthyl ester) (KpQ ^ : 86 - 90°C)
2- cyan- l- aziridin- carboxylsyre-( 1- naft hylest er) oljeaktig produkt 2-cyano-l-aziridine-carboxylic acid-(1-naphthyl ester) oily product
15-Klormaursyre-(4-methylfenylester) (Kp30<:><10>5 -<106>°<C>) 15-Chloroformic acid-(4-methylphenyl ester) (Kp30<:><10>5 -<106>°<C>)
2- cyan- 1- aziridin- carboxylsyre-( 4- methylfenylester)2- cyano- 1- aziridine- carboxylic acid-(4- methylphenyl ester)
Smp. 88 - 90°C (isopropanol)Temp. 88 - 90°C (isopropanol)
16. Klormaursyre-(2,4-dimethylfenylester) (Kpl2: 100 - 101°C) 2- cyan- 1- aziridin- carboxylsyre-( 2, 4- dimethylfenylester) 16. Chloroformic acid-(2,4-dimethylphenylester) (Kpl2: 100 - 101°C) 2-cyano-1-aziridine-carboxylic acid-(2,4-dimethylphenylester)
Smp. 90 - 91°C (ethanol) • Temp. 90 - 91°C (ethanol) •
17. Klormaursyre-(4-sek-butyl-fenylester) ■ (Kp12 : 122 - 123°C) 2-cy an- 1- aziridin- carboxylsyre-( 4- sek- butyl- fenylester) 17. Chloroformic acid-(4-sec-butyl-phenylester) ■ (Kp12 : 122 - 123°C) 2-cyano-1-aziridine-carboxylic acid-(4-sec-butyl-phenylester)
Smp. 74 - 75°C (ligroin)Temp. 74 - 75°C (Ligroin)
18• Klormaursyre-(4-bifenylest er) 18• Chloroformic acid-(4-biphenyl ester)
2- cyan- 1- aziridin- carboxylsyre-( 4- bifenylester)2- cyano- 1- aziridine- carboxylic acid-( 4- biphenyl ester)
Smp. 107 - 109°C Temp. 107 - 109°C
19. Klormaursyre-( 4-methoxyf enylester) (Kp12: 115 - H7°C) 2- cyan- 1- aziridin- carboxylsyre-( 4- methoxyfenylest er) 19. Chloroformic acid-(4-methoxyphenyl ester) (Kp12: 115 - H7°C) 2-cyano-1-aziridine-carboxylic acid-(4-methoxyphenyl ester)
Smp. 54 - 57°C (diisopropylether)Temp. 54 - 57°C (diisopropyl ether)
20. Klormaursyre-(4-klor-2-methoxyf enylester) (Kp2Q : 138 l40°C) 2-cyan-l-aziridin-carbo xylsyre-( 4- klor- 2- methoxyfenylester) Smp. 114 - H5°C (isopropanol) 21. Klormaursyre-(2-fluorfenylester) (Kp 2 : 68 - 70°C) 2-cyan-l-aziridin-c arboxylsyre-( 2- fluorfenylest er) 20. Chloroformic acid (4-chloro-2-methoxyphenyl ester) (Kp2Q : 138 l40°C) 2-cyano-1-aziridine-carboxylic acid-(4-chloro-2-methoxyphenyl ester) M.p. 114 - H5°C (isopropanol) 21. Chloroformic acid-(2-fluorophenyl ester) (Kp 2 : 68 - 70°C) 2-cyano-l-aziridine-carboxylic acid-(2-fluorophenyl ester)
Smp. 55 - 56°C (isopropanol/vann)Temp. 55 - 56°C (isopropanol/water)
22.Klormaursyre-(4-trifluormethylfenylester) (Kp12: 82 - 84°C) 2- cyan- l- aziridin- carboxylsyre-( 4~ t rifluormethylfenylester) Smp. 75 - 77°C (diisopropylether) 23. Klormaursyre-(4-klorfenylester) (Kp12: 97 - 99°C) 2-cyan-l-azi ridin- ca rboxyls yre-( 4- klorfenylest er) 22.Chloroformic acid-(4-trifluoromethylphenylester) (Kp12: 82 - 84°C) 2-cyano-l-aziridine-carboxylic acid-(4-trifluoromethylphenylester) M.p. 75 - 77°C (diisopropyl ether) 23. Chloroformic acid-(4-chlorophenyl ester) (Kp12: 97 - 99°C) 2-cyan-1-aziridin-carboxylic acid-(4-chlorophenyl ester)
Smp. 79 - 82°C (diisopropylether)Temp. 79 - 82°C (diisopropyl ether)
24. Klormaursyre-(2,4-diklorfenylester) (Kpg : 112 - H7°C) 2- cyan- 1- aziridin-carboxylsyre-( 2, 4- diklorfenylester) 24. Chloroformic acid-(2,4-dichlorophenyl ester) (Kpg : 112 - H7°C) 2-cyano-1-aziridine-carboxylic acid-(2,4- dichlorophenyl ester)
Smp. 82 - 84°CTemp. 82 - 84°C
25. Klormaursyre-(2,4,5-triklorfenylester) (Smp.: 58 - 6o°C) 2- cyan- l- aziridin- carboxylsyre-( 2, 4;5- triklorfenylester) Smp. 100 - 103°C (diisopropylether) 26. Klormaursyre-(4-bromfenylester) (Kp12: 111 - H3°C) 2- cyan- 1- aziridin- carboxylsyre-( 4- bromfenylester) 25. Chloroformic acid-(2,4,5-trichlorophenyl ester) (Mp.: 58 - 6o°C) 2-cyano-l-aziridine-carboxylic acid-(2,4;5-trichlorophenyl ester) M.p. 100 - 103°C (diisopropyl ether) 26. Chloroformic acid-(4-bromophenyl ester) (Kp12: 111 - H3°C) 2-cyano-1-aziridine-carboxylic acid-(4-bromophenyl ester)
Smp. 96 - 100°C (diisopropylether) Temp. 96 - 100°C (diisopropyl ether)
27. Klormaursyre-(3-nitrofenylester) (KpQ ^ •: 120 - 122°C) 2- cyan- l- aziridin- carboxylsyre-( 3- nitrofenylest er) 27. Chloroformic acid-(3-nitrophenyl ester) (KpQ ^ •: 120 - 122°C) 2-cyano-l-aziridine-carboxylic acid-(3-nitrophenyl ester)
Smp. 98 - 100°C (isopropanol)Temp. 98 - 100°C (isopropanol)
28- Klormaursyre-(4-nitrofenylester) 28- Chloroformic acid-(4-nitrophenyl ester)
2- cyan- l- aziridin- carbo xylsyre-( 4- nitrofenylester)2-cyano-l-aziridine-carboxylic acid-(4-nitrophenyl ester)
Smp. 107 -.111°C (diisopropylether)Temp. 107 -.111°C (diisopropyl ether)
29. Klormaursyre-(4-methylthiofenylester) (KpQ 2 : 108°C) 2- cyan- l- aziridin-ca rboxylsyre-( 4- methylthiofenylester) Smp. 73 - 75°C (isopropanol) 30. Klormaursyre-(2-methylsulfonylfenylester) (Smp. 100 - 103°C) 2-cyan-l-azirid in- carboxylsyre-( 2- methylsulfonylf enylest er) Smp. 145 - 150°C (isopropanol) 31. Klormaursyre-(3-formylfenylester) (KpQ ^ : 125°C) 2- cyan- l- aziridin- carboxylsyre-( 3- formylfenylest er) oljeaktig produkt 32. Klormaursyre-(4-acetyl.fenylester) (Kp,- : 121 - 123°C) 29. Chloroformic acid-(4-methylthiophenyl ester) (KpQ 2 : 108°C) 2-cyano-l-aziridine-carboxylic acid-(4-methylthiophenyl ester) M.p. 73 - 75°C (isopropanol) 30. Chloroformic acid-(2-methylsulfonylphenyl ester) (Mp. 100 - 103°C) 2-cyano-l-aziride in- carboxylic acid-(2-methylsulfonylphenyl ester) Mp. 145 - 150°C (isopropanol) 31. Chloroformic acid-(3-formylphenyl ester) (KpQ ^ : 125°C) 2-cyano-l-aziridine-carboxylic acid-(3-formylphenylester) oily product 32. Chloroformic acid-(4- acetyl.phenyl ester) (Kp,- : 121 - 123°C)
2 ->cy an- l- aziridin-car boxylsyre-( 4- acetylfenylester)2 ->cy an- l-aziridine-carboxylic acid-(4- acetylphenyl ester)
Smp. 104 - 107°C Temp. 104 - 107°C
33-Klormaursyre-(4-carbomethoxyfenylester) (Smp.: 47 - 50°C) 33-Chloroformic acid-(4-carbomethoxyphenyl ester) (M.P.: 47 - 50°C)
2- cyan- l- aziridin-carboxylsy re-( 4- carbomethoxyfenylest er) Smp. 86 - 87°C (isopropanol) 2-cyano-1-aziridine-carboxylic acid-(4-carbomethoxyphenyl ester) M.p. 86 - 87°C (isopropanol)
34. Klormaursyre-(4-cyanfenylester) (Kp O j 1: 92- 94°C) 2- cyan- 1- a ziridin- carboxylsyre-( 4-cyan fenylest er) 34. Chloroformic acid-(4-cyanophenyl ester) (Kp O j 1: 92-94°C) 2-cyano-1-aziridine-carboxylic acid-(4-cyanophenyl ester)
Smp. 95 -. 99°C (eddikester/ligroin)Temp. 95 -. 99°C (acetic acid/naphtha)
35.Klormaursyre-(2-fthalimidoethylester) (Smp. 75 - 77°C) 2- cyan- l- aziridin- carboxyisyre-( 2- fthalimidoethylester) Smp. 160 - l63°c (ethanol) 35. Chloroformic acid-(2-phthalimidoethyl ester) (Mp. 75 - 77°C) 2-cyano-l-aziridine-carboxylic acid-(2- phthalimidoethyl ester) M.p. 160 - 163°c (ethanol)
Forbindelser som ble erholdt som "oljeaktig produkt", ble'karakterisert vedNMR- og massespektroskopi. Compounds obtained as "oily product" were characterized by NMR and mass spectroscopy.
Claims (5)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762656323 DE2656323A1 (en) | 1976-12-11 | 1976-12-11 | Immunostimulant aziridine carboxylic acid derivs. - with substits. in 2-position |
| DE19772740248 DE2740248A1 (en) | 1977-09-07 | 1977-09-07 | Immunostimulant aziridine carboxylic acid derivs. - with substits. in 2-position |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO774225L true NO774225L (en) | 1978-06-13 |
Family
ID=25771246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO774225A NO774225L (en) | 1976-12-11 | 1977-12-09 | PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS5373555A (en) |
| AR (1) | AR218645A1 (en) |
| AT (1) | AT361496B (en) |
| AU (1) | AU3137877A (en) |
| CH (1) | CH637116A5 (en) |
| CS (1) | CS198277B2 (en) |
| DD (1) | DD132659A5 (en) |
| DK (1) | DK550377A (en) |
| ES (1) | ES464855A1 (en) |
| FI (1) | FI773711A7 (en) |
| FR (1) | FR2373528A1 (en) |
| GB (1) | GB1559916A (en) |
| IL (1) | IL53549A (en) |
| IT (1) | IT1089634B (en) |
| LU (1) | LU78659A1 (en) |
| NL (1) | NL7713460A (en) |
| NO (1) | NO774225L (en) |
| NZ (1) | NZ185901A (en) |
| OA (1) | OA05817A (en) |
| PL (1) | PL202798A1 (en) |
| PT (1) | PT67378B (en) |
| SE (1) | SE7713876L (en) |
| SU (1) | SU751322A3 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2833986A1 (en) * | 1978-08-03 | 1980-02-21 | Boehringer Mannheim Gmbh | IMMUNITIMULATING N-SUBSTITUTED AZIRIDINE-2-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES |
| JPS62111909A (en) * | 1985-11-09 | 1987-05-22 | Shiseido Co Ltd | Nail beautifying cosmetic |
| US6476236B1 (en) * | 2001-11-26 | 2002-11-05 | The Arizona Board Of Regents | Synthesis of 2-cyanoaziridine-1-carboxamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE110492C (en) * |
-
1977
- 1977-12-05 AR AR270243A patent/AR218645A1/en active
- 1977-12-06 IL IL53549A patent/IL53549A/en unknown
- 1977-12-06 NL NL7713460A patent/NL7713460A/en not_active Application Discontinuation
- 1977-12-06 DD DD7700202433A patent/DD132659A5/en unknown
- 1977-12-06 SU SU772551049A patent/SU751322A3/en active
- 1977-12-07 SE SE7713876A patent/SE7713876L/en unknown
- 1977-12-07 ES ES464855A patent/ES464855A1/en not_active Expired
- 1977-12-07 PT PT67378A patent/PT67378B/en unknown
- 1977-12-07 CH CH1501677A patent/CH637116A5/en not_active IP Right Cessation
- 1977-12-07 GB GB50910/77A patent/GB1559916A/en not_active Expired
- 1977-12-08 NZ NZ185901A patent/NZ185901A/en unknown
- 1977-12-08 LU LU7778659A patent/LU78659A1/xx unknown
- 1977-12-08 FI FI773711A patent/FI773711A7/en not_active Application Discontinuation
- 1977-12-08 AU AU31378/77A patent/AU3137877A/en active Pending
- 1977-12-09 JP JP14870777A patent/JPS5373555A/en active Pending
- 1977-12-09 FR FR7737133A patent/FR2373528A1/en active Granted
- 1977-12-09 IT IT30553/77A patent/IT1089634B/en active
- 1977-12-09 OA OA56333A patent/OA05817A/en unknown
- 1977-12-09 NO NO774225A patent/NO774225L/en unknown
- 1977-12-09 CS CS778259A patent/CS198277B2/en unknown
- 1977-12-09 PL PL20279877A patent/PL202798A1/en unknown
- 1977-12-09 AT AT882877A patent/AT361496B/en not_active IP Right Cessation
- 1977-12-09 DK DK550377A patent/DK550377A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SU751322A3 (en) | 1980-07-23 |
| AT361496B (en) | 1981-03-10 |
| CH637116A5 (en) | 1983-07-15 |
| DD132659A5 (en) | 1978-10-18 |
| FR2373528A1 (en) | 1978-07-07 |
| ES464855A1 (en) | 1978-08-01 |
| IT1089634B (en) | 1985-06-18 |
| AU3137877A (en) | 1979-06-14 |
| PT67378B (en) | 1979-05-18 |
| AR218645A1 (en) | 1980-06-30 |
| LU78659A1 (en) | 1979-02-02 |
| CS198277B2 (en) | 1980-05-30 |
| PT67378A (en) | 1978-01-01 |
| IL53549A (en) | 1981-11-30 |
| GB1559916A (en) | 1980-01-30 |
| OA05817A (en) | 1981-05-31 |
| NZ185901A (en) | 1979-06-08 |
| ATA882877A (en) | 1980-08-15 |
| JPS5373555A (en) | 1978-06-30 |
| SE7713876L (en) | 1978-06-12 |
| IL53549A0 (en) | 1978-03-10 |
| DK550377A (en) | 1978-06-12 |
| NL7713460A (en) | 1978-06-13 |
| FR2373528B1 (en) | 1981-11-13 |
| FI773711A7 (en) | 1978-06-12 |
| PL202798A1 (en) | 1979-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998009949A1 (en) | Novel acetamide derivatives and protease inhibitors | |
| CN100402496C (en) | Compounds useful as matrix metalloproteinase inhibitors | |
| FI59991B (en) | PROCEDURE FOR THE FRAMSTATION OF AV 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES AND DERAS SALTER | |
| US6372933B1 (en) | Process for preparing certain phenyl urea compounds | |
| CN112272665B (en) | Method for preparing lifalast | |
| NO774225L (en) | PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES | |
| KR101881918B1 (en) | New process for the synthesis of acylsulfonamides derivatives | |
| US4376731A (en) | 1-Aziridine carboxylic acid derivatives with immunostimulant activity | |
| US3978126A (en) | N-hydroxy-amidine compounds | |
| US4203904A (en) | Alkylation of aniline with a lactone in the presence of a base | |
| JPS63203672A (en) | Novel heterocyclic compound | |
| SU1121261A1 (en) | Process for preparing heterylthiocarboxylic acid arylamides | |
| SU489319A3 (en) | The method of obtaining coumarin derivatives | |
| JPS6360969A (en) | Production of imidazole derivative | |
| CA2268544A1 (en) | N.alpha.-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids | |
| JP2671401B2 (en) | .ALPHA.-Aminothioacetamide derivative and its production method | |
| US5672711A (en) | Process for manufacturing cephem derivatives | |
| JPS6124379B2 (en) | ||
| HU201516B (en) | Process for producing 2-cyano-2-oximinoacetamide derivatives | |
| JP4302974B2 (en) | Method for producing oxazole compound | |
| Li et al. | Asymmetric synthesis and absolute stereochemistry of 4, 4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors | |
| KR800001142B1 (en) | Process for 1-aziridine-carboxylic ester derivatives | |
| EP0082523A2 (en) | Intermediates for the preparation of 4-phenyl-1,3-benzodiazepins and methods for preparing the intermediates | |
| KR100665761B1 (en) | Hydroxamic Acid and Carboxylic Acid Derivatives | |
| RU1794941C (en) | N-(3-nitro-4-chlorophenylsulfonyl)-5-chloroanthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-(3-nitro-4-chlorophenylsulfonyl)amino-5- chlorobenzamide showing antitrichocephaliasis activity |